Bioasis Technologies Inc., of Guilford, Conn., said it intends to complete a nonbrokered private placement of units at a price of CA28 cents (US20 cents) per unit, for gross proceeds of about CA$1 million. Proceeds will be used to support ongoing research and development, clinical development, manufacturing and other activities in respect of the company's clinical development pipeline and for working capital and general corporate purposes.